Clinical Trial Update: Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial assessing metabolic activity and transcriptional profiling in melanoma patients treated with pazopanib alone or with paclitaxel; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pazopanib (Pazopanib)

Snippet

Sponsor: University of Zurich | Conditions: Melanoma | Phase 2 | Status: COMPLETED